Cardiovascular Revascularization Medicine Cardiovascular Revascularization Medicine RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The boy who cried wolf
In the past decades, evidence has mounted for the benefits of primary percutaneous coronary intervention (PCI) over thrombolysis during ST-segment elevation myocardial infarction (STEMI) as it establishes more consistent and predictable epicardial artery recanalization, reduces recurrent ischemia and reinfarction, and improves survival [1]. Hospitals with established interventional cardiology programs have opened and maintained primary PCI programs with dedicated teams of interventional cardiologists, nurses, and technicians who are available around the clock to perform urgent coronary revascularization for STEMI patients....
Source: Cardiovascular Revascularization Medicine - May 31, 2016 Category: Cardiology Authors: Israel M. Barbash, Victor Guetta Tags: Editorial Source Type: research

Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
To compare early and late mortality of transfemoral (TF) and transapical (TA) transcatheter aortic valve replacement (TAVR) patients and assess predictors for mortality. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 13, 2016 Category: Cardiology Authors: Edward Koifman, Marco Magalhaes, Sarkis Kiramijyan, Ricardo O. Escarcega, Romain Didier, Rebecca Torguson, Itsik Ben-Dor, Paul Corso, Christian Shults, Lowell Satler, Augusto Pichard, Ron Waksman Tags: Clinical Source Type: research

Impact of Transfemoral Versus Transapical Access on Mortality Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
To compare early and late mortality of TF and TA TAVR patients and assess predictors for mortality. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 13, 2016 Category: Cardiology Authors: Edward Koifman, Marco Magalhaes, Sarkis Kiramijyan, Ricardo O. Escarcega, Romain Didier, Rebecca Torguson, Itsik Ben-Dor, Paul Corso, Christian Shults, Lowell Satler, Augusto Pichard, Ron Waksman Source Type: research

In vitro performance investigation of bioresorbable scaffolds – Standard tests for vascular stents and beyond
Biodegradable polymers are the main materials for coronary scaffolds. Magnesium has been investigated as a potential alternative and was successfully tested in human clinical trials. However, it is still challenging to achieve mechanical parameters comparative to permanent bare metal (BMS) and drug-eluting stents (DES). As such, in vitro tests are required to assess mechanical parameters correlated to the safety and efficacy of the device. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 12, 2016 Category: Cardiology Authors: Wolfram Schmidt, Peter Behrens, Christoph Brandt-Wunderlich, Stefan Siewert, Niels Grabow, Klaus-Peter Schmitz Source Type: research

The impact of prior stroke on the outcome of patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
The present study aimed to evaluate the impact of prior cardiovascular events (CVE) on outcome in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 12, 2016 Category: Cardiology Authors: Romain Didier, Edward Koifman, Sarkis Kiramijyan, Smita I. Negi, Rebecca Torguson, Petros Okubagzi, Augusto D. Pichard, Ron Waksman Tags: Clinical Source Type: research

In vitro performance investigation of bioresorbable scaffolds – standard tests for vascular stents and beyond
Biodegradable polymers are the main materials for coronary scaffolds. Magnesium has been investigated as a potential alternative and was successfully tested in human clinical trials. However, it is still challenging to achieve mechanical parameters comparative to permanent bare metal (BMS) and drug-eluting stents (DES). As such, in vitro tests are required to assess mechanical parameters correlated to the safety and efficacy of the device. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 12, 2016 Category: Cardiology Authors: Wolfram Schmidt, Peter Behrens, Christoph Brandt-Wunderlich, Stefan Siewert, Niels Grabow, Klaus-Peter Schmitz Source Type: research

The Impact of Prior Stroke on the Outcome of Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
The present study aimed to evaluate the impact of prior cardiovascular events (CVE) on outcome in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 12, 2016 Category: Cardiology Authors: Romain Didier, Edward Koifman, Sarkis Kiramijyan, Smita I. Negi, Rebecca Torguson, Petros Okubagzi, Augusto D. Pichard, Ron Waksman Source Type: research

Comparison of clinical outcomes with the utilization of monitored anesthesia care vs. general anesthesia in patients undergoing transcatheter aortic valve replacement
There is no clear consensus in regard to the optimal anesthesia utilization during transcatheter aortic valve replacement (TAVR). The aim was to compare outcomes of transfemoral (TF) TAVR under monitored anesthesia care (MAC) vs. general anesthesia (GA) and evaluate the rates and causes of intra-procedural MAC failure. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - April 27, 2016 Category: Cardiology Authors: Sarkis Kiramijyan, Itsik Ben-Dor, Edward Koifman, Romain Didier, Marco A. Magalhaes, Ricardo O. Escarcega, Smita I. Negi, Nevin C. Baker, Jiaxiang Gai, Rebecca Torguson, Petros Okubagzi, Federico M. Asch, Zuyue Wang, Michael A. Gaglia, Lowell F. Satler, A Source Type: research

Repeat revascularization: percutaneous coronary intervention after coronary artery bypass graft surgery
Repeat myocardial revascularization procedures are markedly different from de novo interventions, with increased procedural risk and technical-demanding complexity.However the number of patients previously treated with coronary artery bypass graft (CABG) that need a repeat revascularization due to graft failure is increasing consistently. Late graft failure, usually caused by saphenous vein grafts (SVG) attrition, is certainly not uncommon. However PCI on degenerated SVG present higher complication rate and worse clinical outcome compared with native arteries interventions. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - April 27, 2016 Category: Cardiology Authors: Roberto Scarsini, Carlo Zivelonghi, Gabriele Pesarini, Corrado Vassanelli, Flavio L. Ribichini Source Type: research

When to close iatrogenic atrial septal defect after percutaneous edge to edge repair of mitral valve regurgitation
We report a case of an 88year old woman with prior transcatheter aortic valve implantation and symptomatic severe degenerative mitral regurgitation. She developed persistent hypoxemia following MitraClip ® procedure, requiring closure of iASD resulting in immediate recovery of hemodynamics. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - April 24, 2016 Category: Cardiology Authors: Satish Chandraprakasam, Ruby Satpathy Source Type: research

When to Close Iatrogenic Atrial Septal Defect After Percutaneous Edge to Edge Repair of Mitral Valve Regurgitation
We report a case of an 88year old woman with prior transcatheter aortic valve implantation and symptomatic severe degenerative mitral regurgitation. She developed persistent hypoxemia following MitraClip® procedure, requiring closure of iASD resulting in immediate recovery of hemodynamics. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - April 24, 2016 Category: Cardiology Authors: Satish Chandraprakasam, Ruby Satpathy Source Type: research

Safety of hydrophilic guidewires used for side-branch protection during stenting and proximal optimization technique in coronary bifurcation lesions
In coronary bifurcation lesions (CBL), hydrophilic guidewires used for side-branch (SB) protection can be withdrawn from underneath the stent easier than other wires. However, the safety of which has not been investigated. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - April 21, 2016 Category: Cardiology Authors: Arka Chatterjee, Brigitta C. Brott, Robin Foley, Oluseun Alli, Mark Sasse, Mustafa Ahmed, Firas Al Solaiman, Gautam Reddy, Sameer Ather, Massoud A. Leesar Source Type: research

Safety of Hydrophilic Guidewires used for Side-Branch Protection During Stenting and Proximal Optimization Technique in Coronary Bifurcation Lesions
Background and Propose.In coronary bifurcation lesions (CBL), hydrophilic guidewires used for side-branch (SB) protection can be withdrawn from underneath the stent easier than other wires. However, the safety of which has not been investigated.Methods/Materials.We performed scanning electron microscopic (SEM) examination of hydrophilic wires—the Whisper and Runthrough wires—used for SB protection during stenting and proximal optimization technique (POT) in 30 patients with CBL. The distal 15cm of the wire was examined every 1mm by SEM and 4500 segments were analyzed to investigate for wire fracture, polymer shearing (...
Source: Cardiovascular Revascularization Medicine - April 21, 2016 Category: Cardiology Authors: Arka Chatterjee, Brigitta C. Brott, Robin Foley, Oluseun Alli, Mark Sasse, Mustafa Ahmed, Firas Al Solaiman, Gautam Reddy, Sameer Ather, Massoud A. Leesar Source Type: research

A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy
To investigate clinical outcomes of percutaneous coronary intervention using a sirolimus-eluting stent with bioresorbable polymer, Ultimaster (BP-SES) compared with a permanent polymer everolimus-eluting stent, Xience (PP-EES) in patients with high risk (ST-segment elevation and non-ST-segment elevation myocardial infarction) acute coronary syndromes (ACS) enrolled in the CENTURY II trial. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - April 14, 2016 Category: Cardiology Authors: Victor A. Jim énez, Andrés Iñiguez, José A. Baz, Mariano Valdés, Alberto Ortiz, André Vuilliomenet, Vicente Mainar, Dariusz Dudek, Shmuel Banai, David Tüller, Jean-Louis Bonnet, Antonio De Miguel, Guillermo Bastos, William Wijns, Shigeru Saito Source Type: research